Navigation Links
United American Healthcare Corporation Announces Increase in Board Size and New Director Nominees
Date:9/1/2010

DETROIT, Sept. 1 /PRNewswire-FirstCall/ -- United American Healthcare Corporation (OTCQB: UAHC) today announced that the Company has increased the size of its Board from seven directors to ten effective with the elections to be held at the Company's upcoming annual meeting of shareholders on Sept. 30, 2010.  

"UAHC is now in an intensive mode of integrating our acquisition of Pulse Systems and growing our combined business for the long term, said William C. Brooks, President and CEO of United American Healthcare.  "To support these efforts the Board and management team determined that a change to our Board was necessary, and that this change should be accomplished in a responsible manner.  We believe the best way to accomplish our strategic goals is through the leadership of a Board that includes significant public company management experience in the healthcare arena and the continuity of governance provided by our current Board members, while adding deep expertise in the medical device industry.  The expansion of UAHC's Board to ten members will enable us to achieve the right balance of relevant industry experience and continuity as we execute our plan for building shareholder value."

With the expansion of the Board, shareholders will be asked to vote for nine directors at the upcoming shareholders' meeting, including two directors for terms expiring at the 2011 annual shareholders' meeting, three directors for terms expiring at the 2012 annual shareholders' meeting and four directors for terms expiring at the 2013 annual shareholders' meeting.  For the upcoming annual meeting, UAHC's Board and management team have nominated five incumbent nominees and four new nominees.  

The incumbent nominees include: Tom A. Goss, Darrell W. Francis, Emmett S. Moten, Jr., Richard M. Brown, D.O. and Ronald E. Hall, Sr.  The new nominees include: Grayson Beck, a professional investor, a 16-year veteran of the medical devi
'/>"/>

SOURCE United American Healthcare Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Ascension Orthopedics Implants First PyroCarbon Shoulder Device in United Kingdom
2. Medco Announces Agreement to Acquire United BioSource Corporation: A Global Medical Research and Scientific Services Leader to Advance Drug Safety and Knowledge
3. Pfenex Inc. Awarded Contract With the United States Federal Government Potentially Totaling Up to $18.8 Million to Develop a Robust Pfenex Expression Technology Based Process for the Production of Bulk Recombinant Protective Antigen (rPA) From Anthr
4. Oxford Finance Corporation and United Orthopedic Group, Inc. Close $20 Million Credit Facility
5. United American Healthcare Corporation Announces Change to Meeting Date for Annual Meeting of Shareholders
6. Amira Announces AM103 and AM803 Patent Grant in the United Kingdom
7. Kiadis Pharma Receives IND Approval From FDA to Start Pivotal Clinical Trial With ATIR(TM) in the United States
8. Pfizer Inc and GoIndustry DoveBid Partner to Auction Surplus Equipment from R&D Facilities Across the United States
9. United Seating & Mobility Launches New Company Website and E-Commerce Store at www.UnitedSeating.com
10. United American Healthcare Corporation Announces Acquisition of Pulse Systems, LLC
11. Pivotal Data for the Investigational Treatment PSD502 for Primary Premature Ejaculation in the United States to be Presented at Major Medical Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... LONDON , July 2, 2015 ... commitment to improving access to HIV treatments   ... a strategic manufacturing agreement to enable production in ... additional source of the dolutegravir active pharmaceutical ingredient (API), and ... the finished product (dolutegravir 50mg, marketed under the name Tivicay®) ...
(Date:7/1/2015)... , July 1, 2015 ContraVir Pharmaceuticals, ... on the development and commercialization of targeted antiviral therapies, ... Fitzgerald Inaugural Healthcare Conference taking place in ... at Le Parker Meridien Hotel. ... overview of the Company,s business during his live presentation ...
(Date:7/1/2015)... 2015 Research ... addition of the "2015 New Frontiers ... Business Challenges, Emerging Technologies, Competitive Landscape" ... New Frontiers in European Clinical Chemistry and ... Landscape is a new five-country strategic analysis ...
Breaking Medicine Technology:ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 2ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 3ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 4ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 5ViiV Healthcare and Desano Pharmaceuticals' Manufacturing Agreement Will Allow Competitive Supply of Dolutegravir in China and Several Developing Countries 6ContraVir to Present at Cantor Fitzgerald Inaugural Healthcare Conference 22015 New Frontiers in European Clinical Chemistry and Immunodiagnostic Markets: Business Challenges, Emerging Technologies, Competitive Landscape 2
... Sunesis,Pharmaceuticals, Inc. (Nasdaq: SNSS ) today announced ... in Elderly AML) Phase 2 clinical,trial of voreloxin ... The REVEAL-1 trial is being conducted in previously ... are unlikely to,benefit from standard induction therapy. The ...
... EASTON, Mass., May 21 Pressure,BioSciences, Inc. (Nasdaq: ... the New York University (NYU) School of Medicine, ... Public Health made presentations,highlighting the advantages of the ... scientific meetings earlier this week.,There were three oral ...
Cached Medicine Technology:Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 2Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 3Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 4Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 5Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City 2Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City 3Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City 4
(Date:7/2/2015)... ... July 02, 2015 , ... Global leader and compression innovator, SIGVARIS ... men. , For style that’s quick on its feet, men will love this ... news for men everywhere because a simple change in socks can dramatically help improve ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... pipeline review 2015” provides comprehensive information on the pipeline products with comparative ... negative pressure wound therapy (NPWT) with 22 market data tables and 4 ...
(Date:7/2/2015)... ... July 02, 2015 , ... Breakthrough ... wrist pain treatment. Dr. Lev Kalika, founder of New York Dynamic Neuromuscular ... authority on the conservative treatment of back, hip, knee and shoulder pain as ...
(Date:7/2/2015)... ... , ... Hand sanitizers have become extremely popular with an annual industry growth ... advocate and radio host Sharon Kleyne, hand sanitizers can effectively decrease the presence of ... sanitizers must be applied correctly and users must be aware of its limitations. ...
(Date:7/2/2015)... Dallas, TX (PRWEB) , ... July 02, 2015 ... ... and the overall status of the Gelatin Capsule manufacturers. The report is a ... industry. , The report depicts the global and Chinese market for the Gelatin ...
Breaking Medicine News(10 mins):Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 2Health News:SIGVARIS Kicks Up Its Style for Men with the Launch of MIDTOWN MICROFIBER in a Dark Navy Stripe Pattern 3Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 2Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 3Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 4Health News:Summer flu season hand sanitizers are most effective when correctly applied reports fresh water advocate Sharon Kleyne 2Health News:Summer flu season hand sanitizers are most effective when correctly applied reports fresh water advocate Sharon Kleyne 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 2Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 3Health News:Gelatin Capsule Market Outlook & Forecast Report 2015-2020 4
... be reacting to varying degrees of energy loss during aerobic ... predisposition. How our bodies react to exercise programs is genetic ... like the level of blood glucose in the body etc. ... scientists from Washington University School of Medicine, exercise can help ...
... the first time in India ,German Remedies, a part of ... treatment // of chronic lymphocytic leukemia. Chronic Lymphocytic Leukemia (CLL) ... progressive disease, which at present has no cure. The disease ... becomes progressively more common with increasing age. ,Fludarabine ...
... scan study of the smokers reveals that the smokers may ... brain’s sensitivity to smoking. ,Researchers have found that the ... in smokers according to the brain responses to the smoking ... into the brain images of smokers in a bid to ...
... Pharma-Planta, wants to produce vaccines and other treatments for major ... to start clinical trials by the year 2009. The project's ... greatest benefit to developing nations where they feel that access ... keeping in mind that human health and the environment are ...
... pounds above ideal body weight. Obesity is slowly becoming a global ... a recent report the number of obese adults in the U.S. ... 15 percent in 1970. ,Obesity not only causes problems ... etc. This has resulted in spiraling of private healthcare costs and ...
... that uncomplicated twin pregnancies may be more risky to ... Imperial College London report that normal monochorionic diamniotic twin ... monochorionic diamniotic twin pregnancy, the twin fetuses share the ... are the most common form of twin pregnancies that ...
Cached Medicine News:Health News:Producing Vaccines from genetically modified crops 2
... The ODEI750D cameras are a new generation of ... between digital and video imaging. Images are captured ... in both video and digital formats. Video signals ... images are sent to the PC as uncompressed ...
Bench Top Horizontal (clean bench) Airflow Cabinet...
... biocompatibility testing at various temperatures, this ... through a clean heating unit to ... to 140F. Transparent panels allow full ... easy access to the work area. ...
... hood ventilates and purifies hazardous chemical ... exhaust. Bonded charcoal filters remove most ... clearance (with access shield open) accommodates ... options include final HEPA filter, work ...
Medicine Products: